Remove Biopharma Remove Pharma Remove Physicians Remove Specialization
article thumbnail

Leading speciality pharmacies in pharma

Pharmaceutical Technology

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. Speciality pharmacies provide comprehensive medications for individuals with serious medical conditions requiring complex treatments, including cancer, cystic fibrosis, haemophilia, hepatitis, HIV, and others.

article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. 5 While the CDC gathers information on these topics for public health planning, there are immediate needs that pharma can address. . What Can Pharma Do? Sunny White. Accessed March 12, 2022.

Pharma 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Handling Economic Uncertainty: The Focus Pharma Marketers Need

Eversana Intouch

Let’s talk about the current economic uncertainty and what it means for pharma marketers. Biopharma valuations are down, especially for public and earlier-stage companies. Talent shortages continue, particularly in executive and specialized R&D roles, while simultaneously layoffs , especially in biotech, are on the rise.

article thumbnail

Handling Economic Uncertainy: The Focus Pharma Marketers Need

Eversana Intouch

Let’s talk about the current economic uncertainty and what it means for pharma marketers. Biopharma valuations are down, especially for public and earlier-stage companies. Talent shortages continue, particularly in executive and specialized R&D roles, while simultaneously layoffs , especially in biotech, are on the rise.

article thumbnail

Gene therapies transform rare disease treatment: hope for patients amidst regulatory, payer and developer challenges

Clarivate

“With gene therapies, like any specialized treatment, payers are going to be very stringent in making sure patients meet the criteria for treatment, given the cost they’re carrying,” said Kiernan.

article thumbnail

For rare disease patients in Mainland China, hope of greater access to treatment

Clarivate

Multinational pharmas seek entry for their products. Multinational pharmas have taken notice of the recent policy focus of Mainland China’s healthcare authorities on rare diseases. China’s rapidly evolving and increasingly dynamic rare disease market provides pharmas an opportunity for strong growth.